European Parliament Passes SPC Manufacturing Waiver

 
• By Dave Wallace

A waiver to allow manufacturing of generics and biosimilars during the term of supplementary protection certificates is on the verge of being realized after the European Parliament approved the Regulation by a large majority.

Brussels
The Parliament Passed The SPC Manufacturing Waiver By A Wide Majority • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin